Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease. 2019

Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
Department of Pediatric Gastroenterology, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York.

UI MeSH Term Description Entries
D010880 Piperidines A family of hexahydropyridines.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075242 Janus Kinase Inhibitors Agents that inhibit JANUS KINASES. JAK Inhibitor,Janus Kinase Inhibitor,JAK Inhibitors,Inhibitor, JAK,Inhibitor, Janus Kinase,Inhibitors, JAK,Inhibitors, Janus Kinase,Kinase Inhibitor, Janus,Kinase Inhibitors, Janus
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D015212 Inflammatory Bowel Diseases Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS. Bowel Diseases, Inflammatory,Inflammatory Bowel Disease

Related Publications

Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
October 2021, Crohn's & colitis 360,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
August 2022, Digestive diseases and sciences,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
October 2018, Alimentary pharmacology & therapeutics,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
September 2016, Gastroenterology & hepatology,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
October 2021, Inflammatory bowel diseases,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
August 2016, Alimentary pharmacology & therapeutics,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
January 1997, Inflammatory bowel diseases,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
January 2005, Drugs,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
March 2017, Nihon rinsho. Japanese journal of clinical medicine,
Michael T Dolinger, and Priya Rolfes, and Becky L Phan, and Marla C Dubinsky
October 2018, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!